Immunocore

A leading TCR biotechnology company focused on delivering first-in-class biological therapies. See our community guidelines:

[Immunocore @Immunocore]

Follow us on LinkedIn for all our latest updates and news! #WeAreIMCR
https://t.co/WDymm0A07m

[Immunocore @Immunocore]

Today is #WorldMentalHealthDay and #WorldSightDay – two causes close to our heart. Regular eye check-ups can make a world of difference, as can looking after our mental health! #WeAreIMCR

[Immunocore @Immunocore]

Our #IT team is #hiring: if you have experience in infrastructure design, system admin and deployment, network and security management… get in touch!
#WeAreIMCR #BiotechJobs
https://t.co/kM6Iqba6GC

[Immunocore @Immunocore]

What does it mean to have a fully integrated, ‘bench to bedside’ process? We asked Shahid Uddin, our Senior Director of Formulation Development & Stability. #LikeIMCR #manufacturing

[Immunocore @Immunocore]

We are pleased to be working with @TheCrick and @RoyalMarsdenNHS on a UK population-level study to better understand responses to #immunotherapy in cancer. #LikeIMCR #oncology

[The Francis Crick Institute @TheCrick]

We're delighted to lead a new project with @RoyalMarsdenNHS to study responses to cancer immunotherapy.

The platform has received £20m+ in public and industry investment and will involve thousands of people from across the UK receiving immunotherapy.

🔗 https://t.co/2uHtn1fc62

[Immunocore @Immunocore]

Join our wide-ranging #CMC function and support our supply chain as Associate Manufacturing & Outsourcing Specialist. #manufacturing #WeAreIMCR #biotechjobs #hiring
https://t.co/hcoU7rPYHw

[Immunocore @Immunocore]

In the 1720s, Onesimus described an early form of inoculation, laying the foundations for future smallpox vaccines. This #BlackHistoryMonth, we celebrate his influence and those of other brilliant black scientists. #WeAreIMCR

[Immunocore @Immunocore]

We end #OvarianCancerAwarenessMonth with a quiz. #IMCRSharing

According to Globocan, what is the projected increase in the number of women diagnosed with ovarian cancer globally by 2050?

Answer in the link: https://t.co/oNqsp23OhN

[Immunocore @Immunocore]

If you have the expertise to navigate complex international IP landscapes and ensure our assets are well protected, we want you on board! Apply now!

https://t.co/HS5UJL92Cv

#WeAreIMCR #hiring #innnovation #biotech

[Immunocore @Immunocore]

With our teams having grown to deliver our mission, we have moved into a new office in Maryland. Thank you to our previous landlords and we look forward to becoming part of the Rio Lakefront business community!

#WeAreIMCR

[Immunocore @Immunocore]

Following a review of our social media strategy, we will close our X account next month. We want to thank each one of you for your support and engagement. You can follow us on LinkedIn @Immunocore and sign-up for updates on our website.

https://t.co/NIJldDDa3C
#WeAreIMCR

[Immunocore @Immunocore]

Each year 324,000 women are diagnosed with #ovarian cancer. The disease is the 8th most common cancer and the most common cause of death from cancer in women, worldwide.

#OvarianCancerAwarenessMonth #GCAM #WeAreIMCR @ocrahope

Ref: https://t.co/oNqsp23OhN

[Immunocore @Immunocore]

A leader in advanced scientific research, our CTO, Annelise Vuidepot, is at the forefront of the latest advancements in TCR therapy. Hear her share insights and current progress in the field: https://t.co/z3F1MfXt3c

#IMCRSharing #immunotherapy

[Immunocore @Immunocore]

Join us as an expert advisor in #healthcare compliance and drive the continuous improvement of our #compliance program and ethical practices. Apply now!
#WeAreIMCR #hiring
https://t.co/BFrwuP72W1

[Immunocore @Immunocore]

Did you know, a fifth of #ovarian cancers are caused by a genetic mutation?

#OvarianCancerAwarenessMonth #GCAM #IMCRSharing @ocrahope

[Immunocore @Immunocore]

#ESMO24 was another great congress for new data and scientific exchange. See you again next year @myESMO! #IMCRSharing #ImmunoOncology

[Immunocore @Immunocore]

#ICYMI for #Investors and #Media: We shared Phase 1 data in ovarian cancer, and insights into the association of T cell fitness with ImmTAC clinical activity: https://t.co/dV7F9VoLiE #OvarianCancerAwarenessMonth #GCAM

[Immunocore @Immunocore]

#News for #Investors and #Media: We will present new insights on the association between T cell fitness and clinical activity of ImmTAC therapies, in an oral session at #ESMO24 today. #immunotherapy

[Immunocore @Immunocore]

If you are at #ESMO24 and want to visualize how our ImmTAC technology works, check our new mechanism of action video on YouTube: https://t.co/CVzoSw8dj2 #immunotherapy #IMCRSharing #innovation

[Immunocore @Immunocore]

Step into the pioneering world of T cell receptor biotechnology, and help us help patients by joining our #clinical team. https://t.co/ceO20qr2aE #BiotechJobs #WeAreIMCR